期刊文献+

尼可地尔对微血管性心绞痛的治疗效果(英文) 被引量:18

Therapeutic effect of nicorandil on microvascular angina pectoris
在线阅读 下载PDF
导出
摘要 目的:观察尼可地尔对微血管性心绞痛的治疗效果。方法:60例微血管性心绞痛患者被随机分为尼可地尔组(30例)和常规治疗组(30例),治疗12周。观察并比较两组患者治疗前后心绞痛发作次数及持续时间、心电图平板运动试验相关参数的变化情况,并比较两组患者治疗的总有效率。结果:与治疗前比较,治疗后两组患者心绞痛发作次数、持续时间、ST段最大压低幅度均明显减少(P<0.05或<0.01),运动总时间明显延长(P<0.01);且与常规治疗组比较,尼可地尔组心绞痛发作次数[(10.3±1.6)次/周比(9.6±1.7)次/周]、ST段最大压低幅度[(0.8±0.3)mm比(0.6±0.2)mm]减少更显著,总运动时间[(7.8±1.4)min比(9.4±1.6)min]明显延长;尼可地尔组总有效率明显升高(73.3%比93.3%)(P<0.05或<0.01)。结论:尼可地尔治疗微血管性心绞痛效果显著,值得进一步研究。 Objective:To observe the therapeutic effect of nicorandil on microvascular angina pectoris (MAP) .Meth‐ods:A total of 60 MAP patients were randomly divided into nicorandil group (n=30) and routine treatment group (n=30) ,and they were treated for 12 weeks .Onset times and duration of angina pectoris ,changes of related pa‐rameters of ECG treadmill exercise test before and after treatment ,and total effective rate were compared between two groups .Results:Compared with before treatment ,there were significant reductions in onset times and duration of angina pectoris and maximum depression extent of ST segment (P〈0.05 or 〈0.01) and significant increase in total exercise time (P〈0.01) after treatment in both groups ;compared with routine treatment group ,there were significant reductions in onset times of angina pectoris [ (10.3 ± 1.6) times/week vs .(9.6 ± 1.7) times/week] and maximum depression of ST segment [ (0.8 ± 0.3) mm vs .(0.6 ± 0.2) mm] ,and significant increase in total exer‐cise time [(7.8 ± 1.4) min vs .(9.4 ± 1.6) min] and total effective rate (73.3% vs .93.3% ) in nicorandil group (P〈0.05 or 〈0.01) .Conclusion:Nicorandil possesses significant therapeutic effect on microvascular angina pectoris , and it is worth further study .
出处 《心血管康复医学杂志》 CAS 2015年第2期164-168,共5页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 微血管性心绞痛 运动试验 尼可地尔 Microvascular angina Exercise test Nicorandil
  • 相关文献

参考文献3

二级参考文献55

  • 1Yagishita A,Tanimoto S,Tanabe K,et al.Cardiac amyloidosis presumptively diagnosed as cardiac syndrome X[J].Circ J,2009,73(7):1349-1351.
  • 2Atmaca Y,Ozdol C,Turhan S,et al.The association of elevated white blood cell count and C-reactive protein with endothelial dysfunction in cardiac syndrome X[J].Acta Cardiol,2008,63(6):723-728.
  • 3Eroglu S,Elif-Sade L,Yildirir A,et al.Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X[J].Acta Cardiol,2009,64(2):207-211.
  • 4Timurkaynak T,Balcioglu S,Arslan U,et al.Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score[J].Saudi Med J,2008,29(3):364-367.
  • 5Sestito A,Lanza GA,Le-Pera D,et al.Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X[J].Pain,2008,139(1):82-89.
  • 6Vermeltfoort IA,Raijmakers PG,Odekerken DA,et al.Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X[J].J Nucl Cardiol,2009,16(3):405-410.
  • 7Cemin R,Erlicher A,Fattor B,et al.Reduced coronary flow reserve and parasympathetic dysfunction in patients with cardiovascular syndrome X[J].Coron Artery Dis,2008,19(1):1-7.
  • 8Kaski JC.Cardiac syndrome X in women:the ro le of oest rogen deficiency[J].Heart,2006,92(3):529.
  • 9Masumoto A,Mohri M,Takeshita A.Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm[J].Int J cardiol,2001,81(2-3):151-156.
  • 10Erdamar H,Sen N,Tavil Y,et al.The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X[J].Coron Artery Dis,2009,20(3):238-244.

共引文献27

同被引文献121

引证文献18

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部